The “relay approach” in obesity management: From incretin mimetics to bariatric surgery and back to pharmacotherapy
Meditsinskiy sovet = Medical Council · 31.05.2026 · 20 (5) · 158-173
DOI: 10.21518/ms2026-155 ↗Kurz gefasst
Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 31.05.2026. Verfasst von V. V. Salukhov und 6 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben.
Abstract (Originalsprache)
This publication is dedicated to the rationale and implementation in clinical practice of a management strategy for obesity, considered as a chronic, multifactorial, and relapsing disease. The main objective of the article is to propose to the medical community the concept of the “relay approach”, which is designed to replace the traditional opposition of conservative and surgical treatment methods with the principle of their synergistic and sequential application. The authors analyze the biological mechanisms of metabolic adaptation and neurohormonal weight defense, explaining the inevitability of relapses with short-term interventions and dictating the need for continuous patient management. The article details scenarios for the use of “second-generation” incretin mimetics. Clear criteria are proposed for initiating therapy with the GLP-1 RA semaglutide, and the tactic of timely treatment escalation – transitioning to the more effective dual GIP/GLP-1 receptor agonist tirzepatide upon reaching a plateau or a suboptimal response – is justified. A new paradigm is taken into account: the integration of pharmacotherapy with bariatric surgery. The article reveals the role of pharmacotherapy as a “bridge therapy” to reduce surgical risks in patients with severe obesity and as a “reverse relay” tool for the treatment of postoperative weight regain. Separate sections are devoted to optimizing patient conditions in specific clinical situations, including preconception and orthopedic preparation, as well as achieving remission of obstructive sleep apnea syndrome. A differentiated approach is formulated for type 2 diabetes mellitus: a “dual-target strategy” is articulated, taking into account not only weight-reducing efficacy but also economic cost-effectiveness and the organ-protective properties of the medications. This article represents a comprehensive guide aimed at forming multidisciplinary teams to ensure long-term control over the patient’s metabolic health and achieve sustained remission of associated complications.
Zitieren
APA
Salukhov, V. V., Galstyan, G. R., Neimark, A. E., Samoylov, V. S., Khalimov, Y. S., Karonova, T. L., & Sukhotskaia, N. A. (2026). The “relay approach” in obesity management: From incretin mimetics to bariatric surgery and back to pharmacotherapy. Meditsinskiy sovet = Medical Council, 20(5), 158-173. https://doi.org/10.21518/ms2026-155
Vancouver
Salukhov VV, Galstyan GR, Neimark AE, Samoylov VS, Khalimov YS, Karonova TL, et al. The “relay approach” in obesity management: From incretin mimetics to bariatric surgery and back to pharmacotherapy. Meditsinskiy sovet = Medical Council. 2026;20(5):158-173. doi:10.21518/ms2026-155
BibTeX
@article{Salukhov2026,
author = {Salukhov, V. V. and Galstyan, G. R. and Neimark, A. E. and Samoylov, V. S. and Khalimov, Yu. Sh. and Karonova, T. L. and Sukhotskaia, N. A.},
title = {The “relay approach” in obesity management: From incretin mimetics to bariatric surgery and back to pharmacotherapy},
journal = {Meditsinskiy sovet = Medical Council},
year = {2026},
volume = {20},
number = {5},
pages = {158--173},
doi = {10.21518/ms2026-155}
}
EUVIMED